These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22701022)

  • 41. Therapeutic targets of hypercholesterolemia: HMGCR and LDLR.
    Ma S; Sun W; Gao L; Liu S
    Diabetes Metab Syndr Obes; 2019; 12():1543-1553. PubMed ID: 31686875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PharmGKB: very important pharmacogene--HMGCR.
    Medina MW; Sangkuhl K; Klein TE; Altman RB
    Pharmacogenet Genomics; 2011 Feb; 21(2):98-101. PubMed ID: 20084049
    [No Abstract]   [Full Text] [Related]  

  • 43. The Statin Target HMG-Coenzyme a Reductase (Hmgcr) Regulates Sleep Homeostasis in
    Alsehli AM; Liao S; Al-Sabri MH; Vasionis L; Purohit A; Behare N; Clemensson LE; Williams MJ; Schiöth HB
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antihypercholesterolemic and antiatherosclerotic potencies of
    Andriani Y; Chaudhry GE; Oksal E; Pangestika I; Ramli NM; Mohamad H; Elvia R; Amir H; Awm E; Sung YY; Muhammad TST
    J Adv Pharm Technol Res; 2020; 11(1):30-35. PubMed ID: 32154156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of statins on the organs: similar or contradictory?
    Ahmadi Y; Ghorbanihaghjo A; Argani H
    J Cardiovasc Thorac Res; 2017; 9(2):64-70. PubMed ID: 28740624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy.
    Osaki Y; Nakagawa Y; Miyahara S; Iwasaki H; Ishii A; Matsuzaka T; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Sone H; Ohashi K; Ishibashi S; Yamada N; Shimano H
    Biochem Biophys Res Commun; 2015 Oct; 466(3):536-40. PubMed ID: 26381177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pleiotropic effects of statins: new therapeutic targets in drug design.
    Bedi O; Dhawan V; Sharma PL; Kumar P
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):695-712. PubMed ID: 27146293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
    Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.
    Lafeber M; Spiering W; van der Graaf Y; Nathoe H; Bots ML; Grobbee DE; Visseren FL
    Am Heart J; 2013 Aug; 166(2):282-289.e1. PubMed ID: 23895811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Choosing the right lipid-regulating agent. A guide to selection.
    Farmer JA; Gotto AM
    Drugs; 1996 Nov; 52(5):649-61. PubMed ID: 9118815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis.
    Rojo-Arreola L; Long T; Asarnow D; Suzuki BM; Singh R; Caffrey CR
    PLoS One; 2014; 9(1):e87594. PubMed ID: 24489942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and pharmacology of fluvastatin.
    Jokubaitis LA
    Br J Clin Pract Suppl; 1996 Jan; 77A():11-5. PubMed ID: 8729584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver.
    Zhang X; Song Y; Feng M; Zhou X; Lu Y; Gao L; Yu C; Jiang X; Zhao J
    J Lipid Res; 2015 May; 56(5):963-71. PubMed ID: 25713102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cosmc regulates O-glycan extension in murine hepatocytes.
    Aryal RP; Noel M; Zeng J; Matsumoto Y; Sinard R; Waki H; Erger F; Reusch B; Beck BB; Cummings RD
    Glycobiology; 2024 Aug; 34(10):. PubMed ID: 39216105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adverse outcome pathway for pregnane X receptor-induced hypercholesterolemia.
    Itkonen A; Hakkola J; Rysä J
    Arch Toxicol; 2023 Nov; 97(11):2861-2877. PubMed ID: 37642746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mevalonate biosynthesis pathway regulates the development and survival of brown adipocytes.
    Kwon J; Yeh YS; Kawarasaki S; Minamino H; Fujita Y; Okamatsu-Ogura Y; Takahashi H; Nomura W; Matsumura S; Yu R; Kimura K; Saito M; Inagaki N; Inoue K; Kawada T; Goto T
    iScience; 2023 Mar; 26(3):106161. PubMed ID: 36895651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intestinal Deletion of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Promotes Expansion of the Resident Stem Cell Compartment.
    Doerfler AM; Han J; Jarrett KE; Tang L; Jain A; Saltzman A; De Giorgi M; Chuecos M; Hurley AE; Li A; Morand P; Ayala C; Goodlett DR; Malovannaya A; Martin JF; de Aguiar Vallim TQ; Shroyer N; Lagor WR
    Arterioscler Thromb Vasc Biol; 2022 Apr; 42(4):381-394. PubMed ID: 35172604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid signalling enforces functional specialization of T
    Lim SA; Wei J; Nguyen TM; Shi H; Su W; Palacios G; Dhungana Y; Chapman NM; Long L; Saravia J; Vogel P; Chi H
    Nature; 2021 Mar; 591(7849):306-311. PubMed ID: 33627871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging views of statin pleiotropy and cholesterol lowering.
    Yu D; Liao JK
    Cardiovasc Res; 2022 Jan; 118(2):413-423. PubMed ID: 33533892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.